| Patent | Date |
|---|
Methods Of Treatment Using Ctla4 Molecules
App 20210115107 - Peach; Robert James ; et al. | 2021-04-22 |
Methods of treatment using CTLA4 mutant molecules
Grant 10,370,428 - Peach , et al. | 2019-08-06 |
Methods Of Treatment Using Ctla4 Molecules
App 20190185538 - Peach; Robert James ; et al. | 2019-06-20 |
Methods Of Treatment Using Ctla4 Mutant Molecules
App 20180134764 - PEACH; Robert James ; et al. | 2018-05-17 |
Methods Of Treatment Using Ctla4 Mutant Molecules
App 20170369549 - PEACH; Robert James ; et al. | 2017-12-28 |
Methods of treatment using CTLA4 mutant molecules
Grant 9,758,565 - Peach , et al. September 12, 2 | 2017-09-12 |
Methods Of Treatment Using Ctla4 Mutant Molecules
App 20150071914 - PEACH; Robert James ; et al. | 2015-03-12 |
Methods of treatment using CTLA4 mutant molecules
Grant 8,785,398 - Peach , et al. July 22, 2 | 2014-07-22 |
Methods Of Treatment Using Ctla4 Mutant Molecules
App 20120052065 - Peach; Robert J. ; et al. | 2012-03-01 |
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
Grant 7,915,395 - Ledbetter , et al. March 29, 2 | 2011-03-29 |
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
Grant 7,829,534 - Larsen , et al. November 9, 2 | 2010-11-09 |
Methods Of Treatment Using Ctla4 Mutant Molecules
App 20100183612 - Peach; Robert J. ; et al. | 2010-07-22 |
Methods of treatment using CTLA4 mutant molecules
Grant 7,700,556 - Peach , et al. April 20, 2 | 2010-04-20 |
Methods of treatment using CTLA4 mutant molecules
App 20090041769 - Peach; Robert J. ; et al. | 2009-02-12 |
Methods for treating immune system diseases using a soluble CTLA4 molecule
Grant 7,455,835 - Cohen , et al. November 25, 2 | 2008-11-25 |
Methods of treatment using CTLA4 mutant molecules
Grant 7,439,230 - Peach , et al. October 21, 2 | 2008-10-21 |
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
App 20080160022 - Larsen; Christian P. ; et al. | 2008-07-03 |
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
Grant 7,304,033 - Larsen , et al. December 4, 2 | 2007-12-04 |
ICOS mutants
Grant 7,235,631 - Chen , et al. June 26, 2 | 2007-06-26 |
Compounds, Compositions And Methods For Inhibiting Or Treating Hiv-1
App 20060264475 - HAFFAR; Omar K. ; et al. | 2006-11-23 |
Soluble CTLA4 mutant molecules and uses thereof
Grant 7,105,166 - Linsley , et al. September 12, 2 | 2006-09-12 |
Soluble CTLA4 mutant molecules
Grant 7,094,874 - Peach , et al. August 22, 2 | 2006-08-22 |
Soluble CTLA4 mutant molecules and uses thereof
App 20050214313 - Peach, Robert J. ; et al. | 2005-09-29 |
Compounds, compositions and methods for inhibiting or treating HIV-1
App 20050203150 - Haffar, Omar K. ; et al. | 2005-09-15 |
System for performing median partitioning as a method for diversity selection and identification of biologically active compounds
App 20040197934 - Bajorath, Jurgen ; et al. | 2004-10-07 |
Soluble CTLA4 mutant molecules and uses thereof
App 20040014171 - Peach, Robert James ; et al. | 2004-01-22 |
Soluble CTLA4 mutant molecules and uses thereof
App 20030219863 - Peach, Robert J. ; et al. | 2003-11-27 |
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
App 20030219876 - Ledbetter, Jeffrey A. ; et al. | 2003-11-27 |
ICOS mutants
App 20030158102 - Chen, Lieping ; et al. | 2003-08-21 |
Methods for treatment of cancer or neoplastic disease and for inhibiting growth of cancer cells and neoplastic cells
App 20030119894 - Murthy, Madiraju S.R. ; et al. | 2003-06-26 |
Soluble Ctla4 Mutant Molecules And Uses Thereof
App 20030035816 - PEACH, ROBERT JAMES ; et al. | 2003-02-20 |
Soluble CTLA4 mutant molecules and uses thereof
App 20020182211 - Peach, Robert J. ; et al. | 2002-12-05 |
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
Grant 6,482,919 - Ledbetter , et al. November 19, 2 | 2002-11-19 |
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
App 20020012989 - Ledbetter, Jeffrey A. ; et al. | 2002-01-31 |
Antibodies against human CD40
Grant 6,312,693 - Aruffo , et al. November 6, 2 | 2001-11-06 |
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
Grant 6,132,992 - Ledbetter , et al. October 17, 2 | 2000-10-17 |
CTLA4/CD28Ig hybrid fusion proteins and uses thereof
Grant 6,090,914 - Linsley , et al. July 18, 2 | 2000-07-18 |
Antibodies against human CD40
Grant 6,051,228 - Aruffo , et al. April 18, 2 | 2000-04-18 |
Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
Grant 5,876,950 - Siadak , et al. March 2, 1 | 1999-03-02 |
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
Grant 5,637,481 - Ledbetter , et al. June 10, 1 | 1997-06-10 |
3,5,3'-triiodothyronine receptor ligands
Grant 5,585,404 - Norinder , et al. December 17, 1 | 1996-12-17 |
| 